TARA - Protara Therapeutics Inc
IEX Last Trade
2
-0.020 -1.000%
Share volume: 149,893
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.02
-0.02
-0.99%
Summary score
19%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.13%
Return on assets
-19.15%
Return on sales
0%
Return on invested capital
158.11%
Total debt ratio
13.44%
Debt ratio change over timeo
-0.92%
Current Ratio
7.94%
Quick Ratio
0%
Cash Position Ratio
6.12%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17.96%
Return on assets
-16.5%
Return on sales
0%
Return on invested capital
76.34%
Total debt ratio
9.69%
Debt ratio change over timeo
-0.99%
Current Ratio
8.87%
Quick Ratio
0%
Cash Position Ratio
8.12%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-12.01%
Return on assets
-11.49%
Return on sales
0%
Return on invested capital
-26.48%
Total debt ratio
6.05%
Debt ratio change over time
-1.15%
Current Ratio
9.53%
Quick Ratio
0%
Cash Position Ratio
8.71%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-114%
Return on assets
-110.37%
Return on sales
0%
Return on invested capital
18.5%
Total debt ratio
-92.1%
Debt ratio change over time
-0.92%
Current Ratio
2.32%
Quick Ratio
0%
Cash Position Ratio
1.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TARA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.13% | -3.05% | 11.55% | 6.27% |
| Return on assets | -19.15% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 158.11% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 13.44% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.92% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 8.87% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.12% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 39% | 40% |
| Short-term ratios | TARA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.96% | -25.62% | 17.94% | 7.14% |
| Return on assets | -16.5% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 76.34% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 41% | 72% | 63% |
| Total debt ratio | 9.69% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.99% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 8.87% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.12% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 28% | 23% | 39% |